BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--ZIVO Bioscience, Inc. (OTCQB: ZIVO), a pioneering biotech/agtech R&D company dedicated to developing therapeutic, medicinal and nutritional product candidates ...
BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--Zivo Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional ...
(RTTNews) - Zivo Bioscience Inc. (ZIVO) announced negative results of a four-month study performed by a third party on behalf of a potential partner company, which included a 42-day coccidiosis trial ...
When it comes to animal health, few challenges are as pervasive and potentially devastating as coccidiosis—a parasitic disease caused by protozoa of the genus Eimeria. Affecting a wide range of ...
All test groups demonstrated statistically significant benefit in broiler health under simulated commercial conditions BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)-- Zivo Bioscience, Inc. (NASDAQ: ZIVO) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback